
Ramsay Générale de (GDS) | Financial Analysis & Statements
Ramsay Générale de Santé S.A. | Large-cap | Healthcare
Ramsay Générale de Santé S.A. | Large-cap | Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2014Income Metrics
Revenue
312.5M
Gross Profit
224.6M
71.87%
Operating Income
17.8M
5.70%
Net Income
-7.7M
-2.46%
Balance Sheet Metrics
Total Assets
6.8B
Total Liabilities
5.7B
Shareholders Equity
1.2B
Debt to Equity
4.79
Cash Flow Metrics
Operating Cash Flow
28.5M
Free Cash Flow
48.7M
Revenue & Profitability Trend
Ramsay Générale de Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 5.2B | 5.0B | 4.7B | 4.3B | 4.0B |
Cost of Goods Sold | 1.2B | 1.1B | 978.8M | 890.7M | 818.6M |
Gross Profit | 4.1B | 3.9B | 3.7B | 3.4B | 3.2B |
Gross Margin % | 77.9% | 78.7% | 79.2% | 79.3% | 79.6% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | - | - | - |
Other Operating Expenses | 719.2M | 678.9M | 516.3M | 749.1M | 704.3M |
Total Operating Expenses | 719.2M | 678.9M | 516.3M | 749.1M | 704.3M |
Operating Income | 187.4M | 184.2M | 218.2M | 293.7M | 265.9M |
Operating Margin % | 3.6% | 3.7% | 4.6% | 6.8% | 6.6% |
Non-Operating Items | |||||
Interest Income | 4.7M | 2.9M | 9.3M | 600.0K | 800.0K |
Interest Expense | 199.1M | 177.0M | 156.4M | 114.6M | 121.3M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -33.4M | -40.8M | 87.7M | 185.2M | 103.3M |
Income Tax | 1.6M | -4.1M | 23.8M | 57.3M | 29.5M |
Effective Tax Rate % | 0.0% | 0.0% | 27.1% | 30.9% | 28.6% |
Net Income | -38.1M | -36.7M | 63.9M | 127.8M | 73.8M |
Net Margin % | -0.7% | -0.7% | 1.4% | 3.0% | 1.8% |
Key Metrics | |||||
EBITDA | 599.7M | 562.9M | 647.3M | 666.5M | 634.9M |
EPS (Basic) | - | €-0.49 | €0.45 | €1.07 | €0.59 |
EPS (Diluted) | - | €-0.49 | €0.45 | €1.07 | €0.59 |
Basic Shares Outstanding | - | 110000000 | 109777778 | 110369389 | 110364389 |
Diluted Shares Outstanding | - | 110000000 | 109777778 | 110369389 | 110364389 |
Income Statement Trend
Ramsay Générale de Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 366.5M | 359.0M | 352.2M | 132.5M | 608.4M |
Short-term Investments | 17.5M | 22.3M | 10.7M | 11.0M | 11.6M |
Accounts Receivable | 527.5M | 687.2M | 538.6M | 422.0M | 323.4M |
Inventory | 125.1M | 125.0M | 118.2M | 111.2M | 111.4M |
Other Current Assets | 260.7M | 269.3M | 329.0M | 574.0M | 406.4M |
Total Current Assets | 1.3B | 1.5B | 1.4B | 1.3B | 1.5B |
Non-Current Assets | |||||
Property, Plant & Equipment | 3.0B | 1.8B | 1.7B | 1.6B | 1.5B |
Goodwill | 4.4B | 4.4B | 4.3B | 4.4B | 3.8B |
Intangible Assets | 205.5M | 209.0M | 213.7M | 244.8M | 241.1M |
Long-term Investments | - | 7.8M | 31.9M | 0 | 0 |
Other Non-Current Assets | - | 100.0K | 400.0K | -100.0K | - |
Total Non-Current Assets | 5.5B | 5.4B | 5.6B | 5.5B | 5.2B |
Total Assets | 6.8B | 6.9B | 7.0B | 6.8B | 6.7B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 432.3M | 457.8M | 471.9M | 410.8M | 343.8M |
Short-term Debt | 335.0M | 355.8M | 279.6M | 231.4M | 237.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 811.1M | 830.9M | 699.6M | 775.6M | 901.8M |
Total Current Liabilities | 1.6B | 1.7B | 1.5B | 1.5B | 1.6B |
Non-Current Liabilities | |||||
Long-term Debt | 3.7B | 3.7B | 3.9B | 3.7B | 3.6B |
Deferred Tax Liabilities | 29.4M | 17.2M | 52.8M | 39.7M | 51.2M |
Other Non-Current Liabilities | 16.2M | 3.7M | 3.7M | 8.9M | 10.2M |
Total Non-Current Liabilities | 4.0B | 4.0B | 4.2B | 4.1B | 4.0B |
Total Liabilities | 5.7B | 5.7B | 5.7B | 5.5B | 5.6B |
Equity | |||||
Common Stock | 82.7M | 82.7M | 82.7M | 82.7M | 82.7M |
Retained Earnings | -54.1M | -53.9M | 49.4M | 118.4M | 65.0M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.2B | 1.2B | 1.3B | 1.2B | 1.1B |
Key Metrics | |||||
Total Debt | 4.1B | 4.1B | 4.1B | 4.0B | 3.9B |
Working Capital | -314.2M | -219.4M | -126.4M | -230.0M | -82.1M |
Balance Sheet Composition
Ramsay Générale de Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -38.1M | -36.7M | 63.9M | 127.8M | 73.8M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 112.7M | 4.6M | 25.8M | -347.0M | -14.0M |
Operating Cash Flow | 298.5M | 192.9M | 220.2M | -123.3M | 228.5M |
Investing Activities | |||||
Capital Expenditures | -135.8M | -166.6M | -165.1M | -175.4M | -173.9M |
Acquisitions | -3.8M | -14.3M | -11.4M | -296.4M | -8.1M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -140.0M | -180.9M | -176.5M | -471.8M | -182.0M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 63.1M | 70.4M | 200.8M | 200.0M | 1.6B |
Debt Repayment | -148.2M | -56.0M | -14.8M | -112.4M | -1.6B |
Financing Cash Flow | -81.4M | 17.7M | 189.5M | 87.6M | -61.4M |
Free Cash Flow | 550.9M | 418.3M | 426.7M | 68.9M | 475.9M |
Net Change in Cash | 77.1M | 29.7M | 233.2M | -507.5M | -14.9M |
Cash Flow Trend
Ramsay Générale de Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
34.13
Price to Book
0.94
Price to Sales
0.21
Profitability Ratios
Profit Margin
-1.03%
Operating Margin
3.58%
Return on Equity
-2.90%
Return on Assets
1.71%
Financial Health
Current Ratio
0.81
Debt to Equity
343.66
Beta
0.19
Per Share Data
EPS (TTM)
€-0.46
Book Value per Share
€10.37
Revenue per Share
€47.48
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
gds | 1.1B | 34.13 | 0.94 | -2.90% | -1.03% | 343.66 |
Emeis S.A | 2.0B | 0.02 | 1.14 | -23.02% | -7.31% | 514.45 |
Orpea | 1.9B | 0.10 | - | 71.75% | 79.36% | 4.85 |
Clariene SE | 1.5B | 9.76 | 0.42 | -1.54% | -1.16% | 209.58 |
Lna Santé S.A | 270.0M | 13.42 | 0.86 | 7.25% | 2.71% | 270.87 |
EssilorLuxottica | 126.5B | 53.38 | 3.35 | 6.44% | 8.74% | 36.58 |
Financial data is updated regularly. All figures are in the company's reporting currency.